Clinical Trials Browser

Gastrointestinal Neoplasms × Ipilimumab × NET × Clear all

NCT02923934 2024-07-24

A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers

Phase 2 Completed

EndocrineGastrointestinalNET

Gastrointestinal Neoplasms, Neuroendocrine Tumors